Relevance of virus-induced immunodepression to oncogenesis.
D000688:Amylose / Q000627:therapeutic use; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D002471:Cell Transformation, Neoplastic; D004912:Erythrocytes / Q000276:immunology; D005622:Friend murine leukemia virus / Q000276:immunology; D007111:Immunity, Cellular / Q000187:drug effects; D007165:Immunosuppression Therapy; D007932:Leucogenenol / Q000627:therapeutic use; D007938:Leukemia / Q000517:prevention & control; D051379:Mice; D009369:Neoplasms / Q000209:etiology*; D009858:Oncogenic Viruses / Q000276:immunology*; D011134:Polysaccharides / Q000627:therapeutic use; D011925:Rauscher Virus / Q000276:immunology; D014734:Vibrio cholerae / Q000276:immunology
D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D011134:Polysaccharides; D007932:Leucogenenol; D000688:Amylose